agilon health inc.
AGL evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for AGL—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$1.90B
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Mar 31, 2026.
Run agilon health inc. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available agilon health inc. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
OCF $24M · Net income $49M
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
3 buys · 0 sells (180d)
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
96
Total value held
$92.7M
| Holder | Shares | Value |
|---|---|---|
| morgan stanley | 2,099,451 | $16.6M |
| north peak capital management, llc | 1,545,537 | $12.2M |
| vanguard capital management llc | 1,077,072 | $8.5M |
| goldman sachs group inc | 1,062,236 | $8.4M |
| aqr capital management llc | 974,897 | $7.7M |
| blackrock, inc. | 873,164 | $6.9M |
| d. e. shaw & co., inc. | 742,218 | $5.9M |
| charles schwab investment management inc | 364,499 | $2.9M |
| jacobs levy equity management, inc | 296,552 | $2.3M |
| geode capital management, llc | 266,112 | $2.1M |
Showing top 10 of 96 institutional holders of agilon health inc.. Open the full 13F history after sign-in.
Short Interest
as of May 20, 2026- % of float
- 7.6%
- Days to cover
- 1.9
- Shares short
- 791,524
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
AGL short interestGovernance
Frequently asked questions
Who is the CEO of agilon health inc.?
Mr. Timothy Patrick O'Rourke is the chief executive officer of agilon health inc. (AGL).
Where is agilon health inc. headquartered?
agilon health inc. (AGL) is headquartered in Westerville, OH, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.